Abstract
Purpose
Transradial access (TRA) has shown lower morbidity and decreased bleeding complications compared to transfemoral access. This study evaluates the safety and feasibility of TRA in thrombocytopenic patients undergoing visceral interventions.
Methods and Materials
Patients who underwent visceral interventions via the radial artery with platelet count less than or equal to 50,000/µL were included in the study. Outcome variables included technical success, access site, bleeding, transfusion, and neurological complications.
Results
From July 1, 2012, to May 31, 2015, a total of 1353 peripheral interventions via TRA were performed, of which 85 procedures were performed in 64 patients (mean age 62.2 years) with a platelet count <50,000/µL (median 39,000/µL). Interventions included chemoembolization (n = 46), selective internal radiation therapy (n = 30), and visceral embolization (n = 9). Technical success was 97.6 % with two cases of severe vessel spasm requiring ipsilateral femoral crossover. There was no major access site, bleeding, or neurological adverse events at 30 days. Minor access site hematomas occurred in five cases (5.9 %) and were treated conservatively in all cases. Pre-procedural platelet transfusions were administered in 23 (27.1 %) cases. There was no statistically significant difference in access site or bleeding complications between the transfused and nontransfused groups.
Conclusions
Transradial visceral interventions in patients with thrombocytopenia are both feasible and safe, possibly without the need for platelet transfusions.
Similar content being viewed by others
References
Crowther MA, et al. Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors. J Crit Care. 2005;20(4):348–53.
Hakim DA, et al. Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial. Am Heart J. 2011;161(2):391–6.
Health, U.D.o. and H. Services, Common terminology criteria for adverse events (CTCAE) version 4.0. National Institutes of Health, National Cancer Institute, 2009.
Kaufman RM, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205–13.
Patel IJ, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23(6):727–36.
Jolly SS, et al. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials. Am Heart J. 2009;157(1):132–40.
Jolly SS, et al. Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. The Lancet. 2011;377(9775):1409–20.
Cooper CJ, et al. Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison. Am Heart J. 1999;138(3):430–6.
Feldman DN, et al. Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention an updated report from the National Cardiovascular Data Registry (2007–2012). Circulation. 2013;127(23):2295–306.
Eichhöfer J, et al. Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience. Am Heart J. 2008;156(5):864–70.
Cox N, et al. Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. Am J Cardiol. 2004;94(9):1174–7.
Chase AJ, et al. Association of the arterial access site at angioplasty with transfusion and mortality: the MORTAL study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart. 2008;94(8):1019–25.
Fischman AM, Swinburne NC, Patel RS. A technical guide describing the use of transradial access technique for endovascular interventions. Tech Vasc Interv Radiol. 2015;18(2):58–65.
Barbeau GR, et al. Evaluation of the ulnopalmar arterial arches with pulse oximetry and plethysmography: comparison with the Allen’s test in 1010 patients. Am Heart J. 2004;147(3):489–93.
Vuurmans T, Hilton D. Brewing the right cocktail for radial intervention. Indian Heart J. 2010;62(3):221.
Pancholy S, et al. Prevention of radial artery occlusion-patent hemostasis evaluation trial (PROPHET study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization. Catheter Cardiovasc Interv. 2008;72(3):335–40.
Sacks D, et al. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9):S199–202.
Bertrand OF, et al. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy. Am Heart J. 2009;157(1):164–9.
Lund C, et al. Cerebral emboli during left heart catheterization may cause acute brain injury. Eur Heart J. 2005;26(13):1269–75.
Hamon M, et al. Silent cerebral infarcts after cardiac catheterization: a randomized comparison of radial and femoral approaches. Am Heart J. 2012;164(4):449–54.
Smilowitz NR, et al. Practices and complications of vascular closure devices and manual compression in patients undergoing elective transfemoral coronary procedures. Am J Cardiol. 2012;110(2):177–82.
Das R, et al. Arterial closure devices versus manual compression for femoral haemostasis in interventional radiological procedures: a systematic review and meta-analysis. Cardiovasc Interv Radiol. 2011;34(4):723–38.
Nathan S, Rao SV. Radial versus femoral access for percutaneous coronary intervention: implications for vascular complications and bleeding. Curr Cardiol Rep. 2012;14(4):502–9.
Wille J, et al. Acute leg ischemia: the dark side of a percutaneous femoral artery closure device. Ann Vasc Surg. 2006;20(2):278–81.
Ortiz D, et al. Access site complications after peripheral vascular interventions: incidence, predictors, and outcomes. Circ Cardiovasc Interv. 2014;7(6):821–8.
Basha J, Dewitt RC, Cable D, Jones GP. Transfusions and their costs: managing patients needs and hospitals economics. Internet J Emerg Intensive Care Med. 2006;9(2).
Bendszus M, Stoll G. Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol. 2006;5(4):364–72.
Jurga J, et al. Cerebral microembolism during coronary angiography: a randomized comparison between femoral and radial arterial access. Stroke. 2011;42(5):1475–7.
Pacchioni A, et al. Risk of brain injury during diagnostic coronary angiography: comparison between right and left radial approach. Int J Cardiol. 2013;167(6):3021–6.
Ruzsa Z, et al. A randomised comparison of transradial and transfemoral approach for carotid artery stenting: RADCAR (RADial access for CARotid artery stenting) study. EuroIntervention. 2014;10(3):381–91.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
J J. Titano, D.M. Biederman, B.S. Marinelli, N.E. Tabori, F.S. Nowakowski: Nothing to disclose; R.S. Patel: Consultant: Sirtex Medical Ltd, Reverse Medical Corp; Speaker’s Bureau: Penumbra, Inc., St. Jude Medical, Inc., Terumo Interventional Systems; E. Kim: Consultant: Onyx Pharmaceuticals; Advisory Board: Onyx Pharmaceuticals, BTG International Ltd; Speaker’s Bureau: BTG International Ltd; R.A. Lookstein: Consultant: Boston Scientific Corporation, Cordis Corp, MEDRAD Interventional/Possis Partnership; Advisory Board: Boston Scientific Corporation; A.M. Fischman: Consultant: Surefire Medical, Terumo Interventional Systems; Advisory Board: Terumo Interventional Systems; Speaker’s Bureau: NeuWave Medical, Surefire Medical, Terumo Interventional Systems.
Ethical standard
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Titano, J.J., Biederman, D.M., Marinelli, B.S. et al. Safety and Feasibility of Transradial Access for Visceral Interventions in Patients with Thrombocytopenia. Cardiovasc Intervent Radiol 39, 676–682 (2016). https://doi.org/10.1007/s00270-015-1264-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-015-1264-3